Bibliography
- Monroig PD, Calin GA. MicroRNA and epigenetics: diagnostic and therapeutic opportunities. Curr Pathobiol Rep 2013;1(1):43-52
- Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435(7043):834-8
- Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103(7):2257-61
- Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin 2014;64(5):311-36
- Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. Jama 2013;310(6):627-36
- Ait Ouakrim D, Dashti SG, Chau R, et al. Aspirin, ibuprofen, and the risk of colorectal cancer in lynch syndrome. J Natl Cancer Inst 2015;107:9
- Dash C, Makambi K, Wallington SF, et al. An exercise trial targeting African-American women with metabolic syndrome and at high risk for breast cancer: Rationale, design, and methods. Contemp Clin Trials 2015;43:33-8
- Krochmal R, Arias S, Yarmus L, et al. Diagnosis and management of pulmonary nodules. Expert Rev Respir Med 2014;8(6):677-91
- Aggarwal S. Targeted cancer therapies. Nature reviews Drug discovery 2010;9(6):427-8
- Nicoloso MS, Sun H, Spizzo R, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 2010;70(7):2789-98
- Bullock M, Silva A, Kanlikilicer-Unaldi P, et al. Exosomal non-coding rnas: diagnostic, prognostic and therapeutic applications in cancer. Non-Coding RNA 2015;1(1):53
- Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: tools for cancer diagnostics. Gut 2009;58(11):1546-54
- Bouchie A. First microRNA mimic enters clinic. Nat Biotechnol 2013;31(7):577